COVID-19: Start with the nose - 04/11/20
| Disclosure of potential conflict of interest: B. J. Lipworth reports grants and personal fees from AstraZeneca, Teva, Chiesi, and Meda; personal fees from Cipla and Glenmark, relevant to the submitted work; personal fees from Lupin and grants and personal fees from Sanofi, outside of the submitted work; and that his son is an employee of AstraZeneca. C. R. Kuo reports personal fees from AstraZeneca and personal fees from Chiesi, relevant to the submitted work. R. Chan reports no relevant conflicts of interest. |
Vol 146 - N° 5
P. 1214 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.

